查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988493

針灸市場：按治療方法、設備、應用和最終用戶分類－2026-2032年全球市場預測

Acupuncture Market by Treatment Modality, Equipment, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，針灸市場價值將達到 7.4121 億美元，到 2026 年將成長至 7.9011 億美元，到 2032 年將達到 119.032 億美元，複合年成長率為 7.00%。

主要市場統計數據
基準年 2025 7.4121億美元
預計年份：2026年 7.9011億美元
預測年份 2032 1,190,320,000 美元
複合年成長率 (%) 7.00%

為針灸在現代醫療保健生態系統中不斷演變的角色制定策略框架，強調整合、臨床路徑和以患者為中心的治療策略。

針灸正超越傳統認知，邁入現代臨床領域，其重要性日益凸顯，整合性、實證實踐和以病人為中心的設計理念成為關鍵。臨床醫生、醫療管理者和醫療設備創新者正從多學科診療路徑、報銷一致性和醫療設備互通性觀點評估針灸，並由此引發關於如何將傳統技術標準化、推廣應用並整合到更廣泛的治療流程中的新問題。

針灸領域正在發生重大變革，而推動變革的因素包括技術進步、監管成熟、患者期望不斷變化以及商業和臨床模式的適應性。

在針灸領域，多項變革正在發生，這些變革正從根本上重塑臨床實踐、商業模式和研究重點。首先，技術創新引入了更精準的刺激技術和輔助監測工具，使臨床醫生能夠收集可操作的生理數據並改善通訊協定。因此，治療流程變得更加標準化，也更容易與其他治療方法結合，從而提高了治療的連續性，並有助於追蹤治療效果。

美國對針灸設備和耗材徵收關稅對供應鏈、採購慣例和臨床可用性的累積影響。

美國近期推出的關稅措施對針灸設備及耗材的採購、供應鏈結構和臨床應用產生了多方面的影響。進口零件和成品關稅的提高，加劇了依賴全球供應鏈的製造商和經銷商的成本壓力，促使他們重新評估籌資策略和與供應商的關係。為此，一些供應商正在加快生產本地化進程，調整產品系列以更多地使用國產零件，或進行策略性庫存佈局，以確保按時向臨床客戶交付產品。

以細分市場為重點的洞察，將臨床環境、治療應用、治療方法選擇和設備特性與其對採用和採購的實際影響聯繫起來。

對市場區隔的深入理解有助於明確臨床影響和商業性機會在服務環境、臨床應用、治療方式和設備類別中的交匯點。基於最終用戶，市場研究可分為診所、家庭醫療保健和醫院三大領域。每種環境都有其獨特的營運限制、人員配備模式和採購週期，這些因素共同決定了部署模式和售後支援需求。在診所，處理能力和病患體驗通常是優先考慮的因素；在家庭醫療保健中，分散式環境下的便攜性和安全性至關重要；而在醫院，則需要與電子健康記錄整合並遵循嚴格的消毒通訊協定。

影響美洲、歐洲、中東、非洲和亞太地區臨床整合、監管途徑和商業化策略的區域趨勢。

區域趨勢對針灸服務和設備的臨床實踐模式、監管預期和分銷管道有顯著影響。在美洲，相關人員往往面臨私人診所網路和綜合醫療保健系統並存的複雜環境，在與支付方溝通時，展現相對療效和報銷途徑的一致性至關重要。這種環境促使醫療服務提供者優先考慮可量化的結果和通訊協定的一致性，以促進針灸療法在醫療機構中的推廣應用。

競爭與合作並存的企業夥伴關係強調產品創新、臨床醫生教育、卓越服務以及推動臨床應用的策略夥伴關係。

針灸生態系統中既有競爭也有合作的力量，它由成熟的設備製造商、靈活的臨床創新者、培訓機構以及連接臨床供給能力的經銷商組成。領先的製造商投資於產品安全、人體工學設計和互通性，以方便記錄和結果追蹤；而臨床創新者則專注於通訊協定最佳化、循證醫學以及諸如生育治療和心理健康輔助性治療等特殊應用場景。

為領導者提供可操作且優先考慮的建議，以加強證據產生、供應鏈韌性、臨床醫生培訓和數位化驅動的護理路徑。

產業領導者應採取具體且優先的行動，以提升臨床應用率、業務永續營運和商業性績效。首先，投資於以結果為導向的臨床研究和可操作的證據生成，這些研究和證據應能直接吸引保險公司和醫院決策者。將研究與真實臨床應用案例結合，有助於將臨床潛力轉化為實際應用。其次，開發模組化的產品和服務包，以滿足診所、居家醫療機構和醫院的多樣化需求，從而減少採購摩擦，並促進可擴展的部署。

採用跨學科、透明的調查方法，結合相關人員對話、比較通訊協定映射和專家檢驗，以確保實際相關性。

為確保證據基礎的嚴謹性和透明度，本研究採用跨學科調查方法，結合與關鍵相關人員的溝通、整合二手文獻以及應用分析架構。主要投入包括對臨床醫生、採購負責人、醫療設備開發人員和臨床研究人員進行結構化訪談，以確定營運限制、應用促進因素和技術要求。這些定性研究結果與臨床指南、監管記錄和同行評審文獻等二級資訊來源進行交叉比對，以闡明臨床標準和安全考慮。

整合策略意義，強調證據一致性、臨床醫生能力建構以及穩健的商業和營運模式，以擴大針灸的普及範圍。

針灸在現代醫療保健中佔據著獨特且不斷拓展的地位，它既遵循傳統療法，又兼顧了當代對安全性、標準化和可衡量療效的期望。在各種臨床環境中，針灸療法展現出多功能性，從輔助疼痛管理到作為輔助療法應用於生育治療和心理健康領域。然而，更廣泛、系統性的應用取決於實證醫學證據的一致性、從業人員的資格認證以及供應鏈的可靠性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：針灸市場依治療方法

  • 耳穴針灸
  • 體針療法
    • 乾針療法
    • 傳統針灸
  • 電針療法

第9章：針灸設備市場

  • 電針療法設備
  • 雷射設備
  • 手工針灸

第10章：針灸市場：依應用領域分類

  • 心理健康
  • 疼痛管理
    • 肌肉骨骼疾病
    • 神經系統疾病

第11章：針灸市場：依最終用戶分類

  • 診所
  • 家庭醫療保健
  • 醫院

第12章：針灸市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：針灸市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 針灸市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國針灸市場

第16章：中國針灸市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3B Scientific GmbH
  • ACUPRESSURE HEALTH CARE PRODUCT
  • Atico Export
  • Beijing Zhongyan Taihe Medical Instrument Co., Ltd.
  • Boen Healthcare Co., Ltd.
  • Erler-Zimmer GmbH & Co. KG
  • GTSimulators
  • Hansraj Nayyar Mediquip Inc
  • HeineScientific
  • Jain Laboratory Instruments PVT.LTD.
  • Jainsons（India）Regd
  • Limbs & Things Ltd
  • Naugra Lab Equipment
  • Shanghai Honglian medical Tech Group
  • Suzhou Hualun Medical Appliance Co,.Ltd
  • Winterthur Medical Zrt.
  • Wujiang Jiachen Acupuncture Devices Co., Ltd.
  • Xincheng Scientific Industries Co., Ltd.
Product Code: MRR-9A2BA9536660

The Acupuncture Market was valued at USD 741.21 million in 2025 and is projected to grow to USD 790.11 million in 2026, with a CAGR of 7.00%, reaching USD 1,190.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 741.21 million
Estimated Year [2026] USD 790.11 million
Forecast Year [2032] USD 1,190.32 million
CAGR (%) 7.00%

A strategic framing of acupuncture's evolving role in modern healthcare ecosystems emphasizing integration, clinical pathways, and patient-centered therapeutic strategies

Acupuncture has moved beyond historical perceptions and into a contemporary clinical discourse where integration, evidence generation, and patient-centered design define relevance. Clinicians, healthcare administrators, and equipment innovators are increasingly evaluating acupuncture through lenses of multidisciplinary care pathways, reimbursement alignment, and device interoperability, prompting fresh questions about how traditional techniques can be standardized, scaled, and incorporated into broader treatment algorithms.

This study begins by situating acupuncture within the evolving architecture of health systems. It emphasizes the convergence of demand-side dynamics - including heightened patient interest in non-pharmacologic pain management and mental health support - with supply-side innovations such as precision stimulation devices and digital monitoring tools. These forces are reframing the role of acupuncture from an adjunct therapy toward an integrated option in care plans where outcomes, safety, and operational efficiency matter.

Through this framing, stakeholders can appreciate how clinical protocols, training pathways, and procurement choices interact with regulatory frameworks to influence adoption. The introduction thus sets a pragmatic tone, focusing on actionable insights and decision-relevant analysis that supports clinicians, administrators, and commercial partners in charting purposeful next steps for acupuncture services and technologies.

Key transformative shifts in acupuncture driven by technology, regulatory maturation, evolving patient expectations, and adaptive commercial and clinical models

The landscape for acupuncture is undergoing several transformative shifts that collectively reshape clinical practice, commercial models, and research priorities. First, technological innovation has introduced more precise stimulation modalities and adjunctive monitoring tools, enabling clinicians to collect actionable physiological data and refine protocols. As a result, treatment delivery is becoming more standardized and amenable to integration with other therapeutic modalities, which improves continuity of care and supports outcome tracking.

Second, regulatory frameworks and professional credentialing have evolved to prioritize safety, standardized training, and evidence-based guidelines. This regulatory maturation reduces variability in practice and increases institutional willingness to integrate acupuncture into care pathways. Third, patient expectations are shifting toward holistic and non-pharmacologic options, driven by concerns about drug side effects and a preference for treatments that emphasize functional recovery and overall wellbeing. Consequently, demand patterns are diversifying beyond traditional pain indications to include fertility support and mental health adjuncts.

Finally, supply chain and commercial models are adapting to these clinical and regulatory changes. Manufacturers and distributors are exploring partnerships with clinical networks, investing in educational initiatives, and aligning product development with clinical evidence needs. Taken together, these shifts create a more resilient and integrated acupuncture ecosystem that favors interoperability, measurable outcomes, and greater institutional acceptance.

Cumulative implications of United States tariff measures on supply networks, procurement practices, and clinical accessibility for acupuncture devices and consumables

Recent tariff actions within the United States have produced layered effects across procurement, supply chain configuration, and clinical access to acupuncture equipment and consumables. Increased duties on imported components and finished devices heighten the cost pressures faced by manufacturers and distributors who rely on global supply bases, prompting a reassessment of sourcing strategies and supplier relationships. In response, some vendors have accelerated efforts to localize production, reconfigure product portfolios to emphasize domestically sourced components, or engage in strategic inventory positioning to preserve delivery timelines for clinical customers.

Clinics and hospitals that procure equipment and consumables are navigating these changes by revisiting purchasing cadences, exploring consolidated contracts, and prioritizing suppliers with transparent supply chain practices. Home healthcare providers and smaller clinics, which often operate on tighter margins, may experience the most immediate procurement constraints, driving interest in multi-use systems and reusable components where clinically appropriate and compliant with safety standards.

Over time, these tariff-related dynamics influence not only price structures but also product availability, timelines for introducing innovative devices, and the competitive landscape as suppliers pursue alternative markets or adjust product strategies. Stakeholders are therefore advised to integrate tariff exposure into procurement risk assessments and to cultivate supplier diversification and contingency planning to sustain clinical service availability and device maintenance commitments.

Segment-focused insights that map clinical settings, therapeutic applications, modality choices, and equipment distinctions to practical adoption and procurement implications

A robust understanding of market segmentation clarifies where clinical impact and commercial opportunity converge across service environments, clinical uses, treatment styles, and equipment categories. Based on End User, the market is studied across Clinics, Home Healthcare, and Hospitals; each setting has distinct operational constraints, staffing models, and procurement cycles that shape adoption patterns and post-sale support requirements. Clinics often prioritize throughput and client experience, home healthcare emphasizes portability and safety in decentralized environments, while hospitals demand integration with electronic medical records and stringent sterilization protocols.

Based on Application, the market is studied across Fertility Treatment, Mental Health, and Pain Management. The Pain Management is further studied across Musculoskeletal Disorders and Neurological Conditions; these differentiated clinical targets require tailored protocols, outcome measures, and training curricula. Fertility treatment pathways emphasize consistency and cross-disciplinary coordination with reproductive medicine teams, whereas mental health applications increasingly function as adjunctive interventions alongside psychotherapy and pharmacotherapy.

Based on Treatment Modality, the market is studied across Auricular Acupuncture, Body Acupuncture, and Electroacupuncture. The Body Acupuncture is further studied across Dry Needling and Traditional Acupuncture; modality selection depends on practitioner credentialing, patient preference, and the specific therapeutic objective. Finally, based on Equipment, the market is studied across Electroacupuncture Devices, Laser Devices, and Manual Needles; each equipment class brings differing regulatory considerations, maintenance profiles, and capital investment requirements that affect procurement decisions and long-term total cost of ownership.

Regional dynamics shaping clinical integration, regulatory pathways, and commercialization strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics materially influence clinical practice patterns, regulatory expectations, and distribution channels for acupuncture services and devices. In the Americas, stakeholders often encounter a mix of private practice networks and integrated health systems, with payer engagement focused on demonstrating comparative effectiveness and reimbursement pathway alignment. This environment incentivizes providers to prioritize quantifiable outcomes and protocol consistency to achieve institutional uptake.

In Europe, Middle East & Africa, regional heterogeneity is pronounced: regulatory regimes and professional credentialing differ across jurisdictions, which creates both challenges and opportunities for standardized training and cross-border distribution. Providers and suppliers operating across these geographies must invest in localized regulatory expertise and adaptable clinical support resources to ensure compliance and clinician confidence.

In Asia-Pacific, historical familiarity with acupuncture and robust practitioner networks coexist with rapid technological modernization and commercial expansion. This region often serves as a proving ground for novel devices and integrated care models, and it shapes global innovation flows. Collectively, these regional distinctions inform strategic entry approaches, partnership models, and localization priorities for suppliers and clinical organizations seeking sustainable scale and clinical impact.

Competitive and collaborative company dynamics emphasizing product innovation, clinician education, service excellence, and strategic partnerships that drive clinical adoption

Competitive and collaborative forces in the acupuncture ecosystem are driven by a mix of established device manufacturers, nimble clinical innovators, training organizations, and distributors that bridge clinical demand with supply capabilities. Leading manufacturers invest in product safety, ergonomic design, and interoperable features that facilitate documentation and outcome tracking, while clinical innovators focus on protocol optimization, evidence generation, and specialty use cases such as fertility and mental health adjuncts.

Distribution and service partners play a critical role in ensuring equipment uptime, sterilization compliance, and clinician training. Effective commercial strategies increasingly prioritize post-sale support, clinician education, and outcome measurement services to differentiate offerings and build long-term institutional relationships. Research collaborations between clinical centers and equipment developers accelerate validation studies and enhance credibility, creating pathways for broader acceptance in hospital systems and integrated care networks.

Finally, strategic partnerships that align device design with digital tools for monitoring and telehealth-enabled care expand the addressable use cases for acupuncture. By linking devices to clinician dashboards and patient engagement platforms, companies can support more consistent treatment protocols, adherence tracking, and integrated care coordination that bolsters clinical value propositions across diverse care settings.

Practical, prioritized recommendations for leaders to strengthen evidence generation, supply chain resilience, clinician training, and digitally enabled care pathways

Industry leaders should pursue concrete, prioritized actions to enhance clinical adoption, operational resilience, and commercial performance. First, invest in outcomes-focused clinical studies and pragmatic evidence generation that speak directly to payer and hospital decision-makers; aligning research with real-world use cases helps translate clinical promise into operational acceptance. Second, develop modular product and service packages that accommodate the differing needs of clinics, home healthcare providers, and hospitals, thereby reducing procurement friction and facilitating scalable rollouts.

Third, strengthen supply chain resilience by diversifying sourcing, validating secondary suppliers, and implementing transparent traceability practices; these measures mitigate the operational impacts of tariff volatility and logistical disruption. Fourth, expand clinician training and certification programs that standardize protocols across modalities such as auricular, body, and electroacupuncture, ensuring consistent quality and safety. Fifth, integrate digital tools that support outcome tracking, remote follow-up, and patient engagement to improve adherence and demonstrate value over time.

Collectively, these recommendations prioritize evidence, operational robustness, and clinician enablement. By aligning commercial strategies with clinical realities and regulatory expectations, industry leaders can drive sustainable growth while supporting better patient outcomes and system-level integration.

A multidisciplinary and transparent research methodology combining stakeholder engagement, comparative protocol mapping, and expert validation to ensure practical relevance

This study employed a multidisciplinary methodology that combines primary stakeholder engagement, secondary literature synthesis, and applied analytical frameworks to ensure a rigorous and transparent evidence base. Primary inputs included structured interviews with clinicians, procurement professionals, device developers, and clinical researchers to surface operational constraints, adoption drivers, and technology requirements. These qualitative insights were triangulated with secondary sources such as clinical guidelines, regulatory records, and peer-reviewed literature to contextualize practice standards and safety considerations.

Analytical techniques encompassed comparative protocol mapping to understand modality differences, supplier capability assessments to evaluate service readiness, and scenario analysis to explore procurement and supply chain permutations. Validation steps included peer review with clinical experts and cross-checks against regulatory guidance to ensure interpretations accurately reflected prevailing practice norms. Where quantitative datasets were referenced for contextual purposes, they were used to illustrate trends rather than to produce predictive estimates.

Overall, the research methodology prioritizes reproducibility, transparency, and practical relevance. Stakeholder input and validation were central to the approach, ensuring that conclusions reflect both operational realities and forward-looking considerations that matter to clinicians, administrators, and commercial partners.

Synthesis of strategic implications emphasizing evidence alignment, clinician enablement, and resilient commercial and operational models to expand acupuncture access

Acupuncture occupies a distinct and expanding niche within contemporary healthcare that balances traditional practice with modern expectations for safety, standardization, and measurable outcomes. Across clinical environments, the therapy demonstrates versatility-from supporting pain management pathways to functioning as adjunctive care in fertility and mental health contexts-yet its broader institutional adoption depends on evidence alignment, practitioner credentialing, and supply chain reliability.

Operationally, clinics, home healthcare providers, and hospitals each present unique adoption levers and constraints; aligning product design, training programs, and procurement approaches to these settings enhances the likelihood of sustained uptake. External forces such as tariff policies and shifting regulatory expectations influence procurement dynamics and the pace at which new devices reach clinical settings, underscoring the importance of strategic sourcing and supplier partnerships.

In summary, stakeholders who prioritize robust evidence generation, clinician enablement, and resilient commercial models are best positioned to translate acupuncture's therapeutic potential into repeatable clinical value. By focusing on integration, outcome measurement, and operational readiness, organizations can expand access to acupuncture services while maintaining safety and quality.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acupuncture Market, by Treatment Modality

  • 8.1. Auricular Acupuncture
  • 8.2. Body Acupuncture
    • 8.2.1. Dry Needling
    • 8.2.2. Traditional Acupuncture
  • 8.3. Electroacupuncture

9. Acupuncture Market, by Equipment

  • 9.1. Electroacupuncture Devices
  • 9.2. Laser Devices
  • 9.3. Manual Needles

10. Acupuncture Market, by Application

  • 10.1. Mental Health
  • 10.2. Pain Management
    • 10.2.1. Musculoskeletal Disorders
    • 10.2.2. Neurological Conditions

11. Acupuncture Market, by End User

  • 11.1. Clinics
  • 11.2. Home Healthcare
  • 11.3. Hospitals

12. Acupuncture Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Acupuncture Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Acupuncture Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Acupuncture Market

16. China Acupuncture Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3B Scientific GmbH
  • 17.6. ACUPRESSURE HEALTH CARE PRODUCT
  • 17.7. Atico Export
  • 17.8. Beijing Zhongyan Taihe Medical Instrument Co., Ltd.
  • 17.9. Boen Healthcare Co., Ltd.
  • 17.10. Erler-Zimmer GmbH & Co. KG
  • 17.11. GTSimulators
  • 17.12. Hansraj Nayyar Mediquip Inc
  • 17.13. HeineScientific
  • 17.14. Jain Laboratory Instruments PVT.LTD.
  • 17.15. Jainsons (India) Regd
  • 17.16. Limbs & Things Ltd
  • 17.17. Naugra Lab Equipment
  • 17.18. Shanghai Honglian medical Tech Group
  • 17.19. Suzhou Hualun Medical Appliance Co,.Ltd
  • 17.20. Winterthur Medical Zrt.
  • 17.21. Wujiang Jiachen Acupuncture Devices Co., Ltd.
  • 17.22. Xincheng Scientific Industries Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUPUNCTURE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ACUPUNCTURE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ACUPUNCTURE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUPUNCTURE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ACUPUNCTURE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACUPUNCTURE MARKET SIZE, BY AURICULAR ACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACUPUNCTURE MARKET SIZE, BY AURICULAR ACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUPUNCTURE MARKET SIZE, BY AURICULAR ACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ACUPUNCTURE MARKET SIZE, BY DRY NEEDLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUPUNCTURE MARKET SIZE, BY DRY NEEDLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ACUPUNCTURE MARKET SIZE, BY DRY NEEDLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUPUNCTURE MARKET SIZE, BY TRADITIONAL ACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ACUPUNCTURE MARKET SIZE, BY TRADITIONAL ACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUPUNCTURE MARKET SIZE, BY TRADITIONAL ACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACUPUNCTURE MARKET SIZE, BY ELECTROACUPUNCTURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUPUNCTURE MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ACUPUNCTURE MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUPUNCTURE MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ACUPUNCTURE MARKET SIZE, BY MANUAL NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUPUNCTURE MARKET SIZE, BY MANUAL NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ACUPUNCTURE MARKET SIZE, BY MANUAL NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ACUPUNCTURE MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUPUNCTURE MARKET SIZE, BY MENTAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ACUPUNCTURE MARKET SIZE, BY MENTAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUPUNCTURE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACUPUNCTURE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUPUNCTURE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ACUPUNCTURE MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUPUNCTURE MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ACUPUNCTURE MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ACUPUNCTURE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUPUNCTURE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ACUPUNCTURE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ACUPUNCTURE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUPUNCTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ACUPUNCTURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACUPUNCTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GCC ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 120. GCC ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. G7 ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NATO ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ACUPUNCTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ACUPUNCTURE MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ACUPUNCTURE MARKET SIZE, BY BODY ACUPUNCTURE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ACUPUNCTURE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ACUPUNCTURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ACUPUNCTURE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ACUPUNCTURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)